Bain Capital Life Sciences Inv Sells 254,110 Shares of Heartflow (NASDAQ:HTFL) Stock

Key Points

• Bain Capital Life Sciences sold a total of 4,000,000 HeartFlow (HTFL) shares across the disclosed transactions (Feb. 4 and Apr. 28–30), raising roughly $115 million in proceeds.
• Following the Apr. 28 sale of 254,110 shares at $30.51, Bain still held 10,194,048 shares (about $311 million in value); that single trade reduced its position by 2.43%.
• HTFL is trading around $29.76 with a market cap of $2.55 billion, and analysts carry a consensus "Moderate Buy" rating with an average price target of $37.67.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) major shareholder Bain Capital Life Sciences Inv sold 254,110 shares of Heartflow stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $30.51, for a total value of $7,752,896.10. Following the completion of the transaction, the insider owned 10,194,048 shares of the company's stock, valued at approximately $311,020,404.48. The trade was a 2.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

Bain Capital Life Sciences Inv also recently made the following trade(s):

• On Thursday, April 30th, Bain Capital Life Sciences Inv sold 948,757 shares of Heartflow stock. The stock was sold at an average price of $29.23, for a total value of $27,732,167.11.
• On Wednesday, April 29th, Bain Capital Life Sciences Inv sold 797,133 shares of Heartflow stock. The stock was sold at an average price of $29.37, for a total value of $23,411,796.21.
• On Wednesday, February 4th, Bain Capital Life Sciences Inv sold 2,000,000 shares of Heartflow stock. The stock was sold at an average price of $28.05, for a total value of $56,100,000.00.

Heartflow Price Performance

Shares of HTFL stock traded up $0.23 on Thursday, reaching $29.76. 1,494,251 shares of the stock were exchanged, compared to its average volume of 1,071,590. The stock has a market cap of $2.55 billion and a PE ratio of -14.95. Heartflow, Inc. has a one year low of $20.13 and a one year high of $41.22. The stock has a 50 day moving average price of $26.11 and a 200 day moving average price of $29.28.

Institutional Investors Weigh In On Heartflow

A number of institutional investors have recently made changes to their positions in the stock. Staley Capital Advisers Inc. grew its stake in shares of Heartflow by 100.0% during the first quarter. Staley Capital Advisers Inc. now owns 14,000 shares of the company's stock worth $341,000 after purchasing an additional 7,000 shares during the period. HB Wealth Management LLC acquired a new stake in shares of Heartflow during the first quarter worth $613,000. Strs Ohio grew its stake in shares of Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company's stock worth $112,000 after purchasing an additional 1,200 shares during the period. XXEC Inc. grew its stake in shares of Heartflow by 564.8% during the first quarter. XXEC Inc. now owns 278,681 shares of the company's stock worth $6,780,000 after purchasing an additional 236,761 shares during the period. Finally, TrueMark Investments LLC grew its stake in shares of Heartflow by 1.4% during the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company's stock worth $654,000 after purchasing an additional 379 shares during the period.

Analyst Upgrades and Downgrades

HTFL has been the subject of a number of recent research reports. Wells Fargo & Company dropped their target price on Heartflow from $38.00 to $35.00 and set an "overweight" rating for the company in a research report on Thursday, March 19th. Canaccord Genuity Group boosted their target price on Heartflow from $40.00 to $43.00 and gave the stock a "buy" rating in a research report on Thursday, March 19th. Finally, JPMorgan Chase & Co. dropped their target price on Heartflow from $40.00 to $35.00 and set an "overweight" rating for the company in a research report on Thursday, March 19th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Heartflow has a consensus rating of "Moderate Buy" and an average price target of $37.67.

About Heartflow

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.